Real-Time Potency Assay for CAR T Cell Killing of Adherent Cancer Cells
Immunotherapy in its various forms has permanently changed the landscape of clinical oncology; antigen receptor (CAR) T cells are one of the most significant adoptive cell therapies to have helped usher in this era. However, the assays currently used to optimize CAR do not necessarily correlate with cancer-killing efficacy, and often require excessive labor or are restricted to providing only end-point data.
Download this application note to discover an assay solution for studying and optimizing CAR T-cells that can:
